Design of antiviral stapled peptides containing a biphenyl cross-linker.

[1]  A. Debnath,et al.  Dual-acting stapled peptides target both HIV-1 entry and assembly , 2013, Retrovirology.

[2]  Hong-Gang Wang,et al.  Rational design of proteolytically stable, cell-permeable peptide-based selective Mcl-1 inhibitors. , 2012, Journal of the American Chemical Society.

[3]  Young Do Kwon,et al.  Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops , 2012, Proceedings of the National Academy of Sciences.

[4]  Jiandong Chen,et al.  Conjugation of spermine enhances cellular uptake of the stapled peptide-based inhibitors of p53-Mdm2 interaction. , 2011, Bioorganic & medicinal chemistry letters.

[5]  Jiandong Chen,et al.  Achieving cell penetration with distance-matching cysteine cross-linkers: a facile route to cell-permeable peptide dual inhibitors of Mdm2/Mdmx. , 2011, Chemical communications.

[6]  J. Sodroski,et al.  Small-molecule CD4 mimics interact with a highly conserved pocket on HIV-1 gp120. , 2008, Structure.

[7]  A. Debnath,et al.  A cell-penetrating helical peptide as a potential HIV-1 inhibitor. , 2008, Journal of molecular biology.

[8]  G. Verdine,et al.  The Challenge of Drugging Undruggable Targets in Cancer: Lessons Learned from Targeting BCL-2 Family Members , 2007, Clinical Cancer Research.

[9]  Asim Kumar Debnath,et al.  Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4. , 2005, Virology.

[10]  Lynn Morris,et al.  Recommendations for the Design and Use of Standard Virus Panels To Assess Neutralizing Antibody Responses Elicited by Candidate Human Immunodeficiency Virus Type 1 Vaccines , 2005, Journal of Virology.

[11]  Xiping Wei,et al.  Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies , 2005, Journal of Virology.

[12]  Hans-Georg Kräusslich,et al.  The HIV-1 capsid protein C-terminal domain in complex with a virus assembly inhibitor , 2005, Nature Structural &Molecular Biology.

[13]  Barbara Müller,et al.  A peptide inhibitor of HIV-1 assembly in vitro , 2005, Nature Structural &Molecular Biology.

[14]  A. Hamilton,et al.  Strategies for targeting protein-protein interactions with synthetic agents. , 2005, Angewandte Chemie.

[15]  Zheng Yang,et al.  Discovery of 4-benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2- (R)-methylpiperazine (BMS-378806): a novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions. , 2003, Journal of medicinal chemistry.

[16]  G. Verdine,et al.  An All-Hydrocarbon Cross-Linking System for Enhancing the Helicity and Metabolic Stability of Peptides , 2000 .

[17]  Helen E Blackwell,et al.  Highly Efficient Synthesis of Covalently Cross-Linked Peptide Helices by Ring-Closing Metathesis. , 1998, Angewandte Chemie.